These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23421411)

  • 21. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient receptor potential channels on sensory nerves.
    Eid SR; Cortright DN
    Handb Exp Pharmacol; 2009; (194):261-81. PubMed ID: 19655110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
    Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
    Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.
    Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions.
    Calixto JB; Kassuya CA; André E; Ferreira J
    Pharmacol Ther; 2005 May; 106(2):179-208. PubMed ID: 15866319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRPV1-Targeted Drugs in Development for Human Pain Conditions.
    Iftinca M; Defaye M; Altier C
    Drugs; 2021 Jan; 81(1):7-27. PubMed ID: 33165872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity.
    Rossato MF; Trevisan G; Walker CI; Klafke JZ; de Oliveira AP; Villarinho JG; Zanon RB; Royes LF; Athayde ML; Gomez MV; Ferreira J
    Biochem Pharmacol; 2011 Feb; 81(4):544-51. PubMed ID: 21087598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermia.
    Ayoub SS; Hunter JC; Simmons DL
    Pharmacol Rev; 2009 Sep; 61(3):225-7. PubMed ID: 19805475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons.
    Leffler A; Fischer MJ; Rehner D; Kienel S; Kistner K; Sauer SK; Gavva NR; Reeh PW; Nau C
    J Clin Invest; 2008 Feb; 118(2):763-76. PubMed ID: 18172555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers.
    Binshtok AM; Bean BP; Woolf CJ
    Nature; 2007 Oct; 449(7162):607-10. PubMed ID: 17914397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion channels in analgesia research.
    Rosenbaum T; Simon SA; Islas LD
    Methods Mol Biol; 2010; 617():223-36. PubMed ID: 20336426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.
    Haanpää M; Treede RD
    Eur Neurol; 2012; 68(5):264-75. PubMed ID: 23037991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hot target on nociceptors: perspectives, caveats and unique features.
    Szolcsányi J
    Br J Pharmacol; 2008 Dec; 155(8):1142-4. PubMed ID: 18997812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Tamayo N; Liao H; Stec MM; Wang X; Chakrabarti P; Retz D; Doherty EM; Surapaneni S; Tamir R; Bannon AW; Gavva NR; Norman MH
    J Med Chem; 2008 May; 51(9):2744-57. PubMed ID: 18386885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical Capsaicin for the Treatment of Neuropathic Pain.
    Sultana A; Singla RK; He X; Sun Y; Alam MS; Shen B
    Curr Drug Metab; 2021; 22(3):198-207. PubMed ID: 33198614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsaicin receptor: TRPV1 a promiscuous TRP channel.
    Pingle SC; Matta JA; Ahern GP
    Handb Exp Pharmacol; 2007; (179):155-71. PubMed ID: 17217056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fire in the hole: pore dilation of the capsaicin receptor TRPV1.
    Bautista D; Julius D
    Nat Neurosci; 2008 May; 11(5):528-9. PubMed ID: 18437189
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
    Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.